2023 Form 5500 filing — Hikma Pharmaceuticals Usa Inc. 401(K) Retirement Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241011141022NAL0011002275001) for Hikma Pharmaceuticals Usa Inc. 401(K) Retirement Plan, reported by Hikma Pharmaceuticals Usa Inc. under EIN 22-3114571 and plan number 002. It reports 2,525 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20241011141022NAL0011002275001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Hikma Pharmaceuticals Usa Inc.
- EIN
- 22-3114571
- Plan number
- 002
- Location
- Berkeley Heights, NJ
- Participants
- 2,525
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $244,033,128
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $244,033,128
- Employer contributions
- $9,133,767
- Participant contributions
- $14,524,690
- Total income / additions
- $56,941,185
- Benefits paid
- $25,415,498
- Administrative expenses
- $273,248
- Total expenses
- $25,693,179
- Net increase / (decrease)
- $31,248,006
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Merrill Lynch, Pierce, Fenner And S | RECORDKEEPER | $272,459 | $0 |